Clinical trial Recruiting at 1 site Observational Ages 18 and up

Can family members spot delirium signs in ICU patients?

Official title: Family Involvement in ICU Delirium Assessment: A Prospective Observational Study Using the FAM-CAM

Run by Shanghai Zhongshan Hospital · NCT07694687 · Data updated 2026-11-12

Family members who know the patient well try a quick delirium check after visiting in the ICU, to see if their observations add information beyond routine nurse screenings.

More Family trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment330 (estimated)
SponsorShanghai Zhongshan Hospital
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedJuly 31, 2027
Study endsJuly 31, 2027
Registry record updatedAugust 10, 2026
Trial IDNCT07694687 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) admitted to the ICU for at least 24 hours, with RASS ≥ -3 at enrollment, and with a willing, Mandarin-speaking family caregiver who has visited the patient.

Probably not a fit

Patients without available or willing family caregivers, or with deep coma/sedation, may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study asks whether family members can help identify delirium signs in adults in the ICU using the FAM-CAM assessment. Family members complete the brief delirium check after visits, while nurses perform standard ICDSC screenings as part of usual care. The study compares family reports with nurse assessments to determine if family input provides complementary information. Participants—both patients and their family caregivers—may participate for up to three days while in the ICU. The goal is to understand if incorporating family observations can improve delirium detection in the ICU setting.

Why it matters

Potential benefit: If successful, the approach could improve early detection of delirium by incorporating family observations into standard ICU screening.

How similar studies have gone: Previous work in ICU delirium has explored caregiver observations, with some studies suggesting added value, but results vary by setting and tool.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

Patients:

* Aged 18 years or older.
* Admitted to the ICU for at least 24 hours.
* Richmond Agitation-Sedation Scale (RASS) score ≥ -3 at the time of enrollment.
* Provided written informed consent to participate. When patients were unable to provide consent, consent was obtained from their legal surrogates.

Family Members:

* Aged 18 years or older.
* Identified as the patient's primary family caregiver.
* Had visited the patient in the ICU at least once.
* Were able to understand and communicate in Mandarin.
* Provided written informed consent and voluntarily agreed to participate.

Exclusion Criteria

Patients:

* Persistent coma or deep sedation throughout the ICU stay, defined as Glasgow Coma Scale (GCS) score ≤ 8 or RASS score of -4 or -5.
* A previously confirmed diagnosis of dementia, a severe psychiatric disorder, or an organic neurological disease.
* Severe hearing impairment that prevented effective communication or study participation.

Family Members:

-Significant visual, hearing, or cognitive problems that prevented them from understanding the study procedures or completing the study assessments.

Where it's running

  • Zhongshan Hospital, Fudan University
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Impact of Family Presence on ICU Patient Outcomes

    This study looks at whether having family members present can help ICU patients need less medication, experience less confusion, spend fewer days on ventilators, and shorten their time in the ICU.

    Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT06770751

  • VR-based sensory stimulation to prevent delirium in ICU patients

    This trial tests whether immersive virtual reality sensory stimulation can delay or reduce delirium in adult ICU patients compared with a non-immersive, tablet-based sensory experience.

    Recruiting Chinese University of Hong Kong · Shenzhen, Guangdong · NCT07806422

  • Digital and Plasma Biomarkers for Delirium in the ICU

    This study tests whether digital biomarkers and blood biomarkers can help detect and predict delirium in older adults in the ICU.

    Recruiting Scripps Health · La Jolla, California and 1 other locations · NCT07694206

  • Therapeutic cuddling for critically ill children

    This project will try therapeutic cuddling to reduce pain, agitation, and delirium in children admitted to the pediatric intensive care unit.

    Recruiting University of Calgary · Calgary, Alberta · NCT07562048

  • Ceribell EEG monitoring for adults in the ICU at high risk of delirium

    This project will test whether a portable Ceribell EEG can detect abnormal brain activity in adult medical, surgical, and cardiovascular ICU patients at high risk for delirium.

    Recruiting Ceribell Inc. · Nashville, Tennessee · NCT07485244

  • Ceribell Delirium Monitor Pilot in ICU Patients

    This pilot test uses the Ceribell Delirium Monitor in ICU patients to see if adding EEG-based delirium monitoring is feasible and how it might affect outcomes.

    Recruiting Ceribell Inc. · Irvine, California and 1 other locations · NCT07449416

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.